NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN
OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG OR JAPAN OR SUCH
OTHER JURISDICTIONS WHERE THE OFFERING AND SALE OF THE NEW SHARES AND
THE SUBSCRIPTION RIGHTS IS RESTRICTED BY LAW.
DiaGenic ASA
Reference is made to the stock exchange announcement made by Diagenic
ASA (the "Company") on 4 April 2014 regarding the rights offering (the
"Rights Offering") of 100,000,000 offered shares in DiaGenic ASA at
subscription price NOK 0.50 per share.
The share capital increase pertaining to the private placement has now
been registered with the Norwegian Register of Business Enterprises.
The Company's new registered share capital is NOK 21,631,974.60,
corresponding to a total of 108,159,873 shares with a nominal value of
NOK 0.20 per share.
The new shares issued in the Rights Offering will be listed immediately
on Oslo Børs.
For further information, please contact:
Lars Christian Stugaard, Acting CEO, DiaGenic ASA, tel +47 23 01 49 06
This information is subject of the disclosure requirements acc. to §5-12
vphl (Norwegian Securities Trading Act)